The 2017 Metro Vancouver Homeless Count counted the number of homeless people over a 24-hour period on March 8, 2017.
The count highlighted the increasing number of seniors that are experiencing homelessness
A total of 380 seniors between 55 and 65 years and another 176 seniors above the age of 65 years responded to the survey on March 8, for a total of 556 seniors. Seniors aged 55 and over represented 23% of the homeless population compared to 18% in 2014. This continues the upward trend of seniors in relation to the total homeless population that has been evident since the 2008 Count. Continue reading
NAFTA re-negotiations may impact Canada’s push for Universal Pharmacare.
U.S. trade negotiators favour the interests of pharmaceutical manufacturers over government and consumers. In the 1980s, the U.S. pharmaceutical industry successfully lobbied the U.S. government to make the elimination of early generic drug competition in Canada part of the Canada-U.S. free trade agreement. In the 1990s, The U.S. made the dismantling of policies favouring Canadian drug manufacturers part of the original NAFTA deal.
Summary of the Globe and Mail article.
- Quebec will seek competitive bids from companies for exclusive supply contracts for generic prescription drugs
- In Quebec, pharmacists were often rebated up to 45 per cent of the price from the drug companies – fees that are illegal in most provinces; the new system caps rebates to pharmacists at 15%
- Quebec spends $800 annually on generic drugs
- Quebec could save 25 per cent to 35 per cent on its $800-million generic-drug bill
Read the entire Globe and Mail article June 28, 2017
Summary of the Globe and Mail Article.
- Financial conflicts of interest are commonplace on guideline committees; 46% of the panelists involved in nine guideline documents received funding from companies that might benefit from a positive mention of their drugs
- In 3 cases, more than 75 per cent of the panelists declared a conflict
- In 2 cases, the guidelines were financed directly by the pharmaceutical industry.
- Doctors rely on guideline panels; official clinical practice guidelines can have a dramatic impact on how drugs are prescribed.
- Canada has no nationwide rules for conflicts of interest; guideline committees set their own conflict standards.
- Pharmaceutical companies pay doctors to deliver speeches, act as consultants, teach continuing medical-education courses, fly to conferences and spearhead clinical trials, among other services.
- The United States Physician Payments Sunshine Act compels companies to divulge all payments of $10 or more to doctors; Canada has no requirement for drug companies to divulge payments to doctors.
Summary of the Globe and Mail article.
- Ten large Canadian drug companies paid $48 million to doctors and health-care-organizations in 2016
- The payment disclosure was voluntary and was an aggregate number; critics say this is not transparent and meaningless
- Only 10 of the 45 members of a drug company consortium took part in the voluntary effort
A very successful PharmaCare Formum was held in Vancouver Quadra on May 26th 2017. This event was sponsored by the Quadra Granville Seniors Group; a group that works with seniors and the community to influence all levels of government to develop and implement supportive policies for seniors. The Forum was attended by 90 people from the Vancouver Quadra, Vancouver Granville, Vancouver East, Vancouver Kingsway, Vancouver South, Delta and Port-Moody-Coquitlam ridings.
Dr. Steve Morgan, UBC
Join the Quadra-Granville Seniors Group to participate in a Forum: “A Better Prescription: How Government Could Make Medicines Safer and more Affordable for our Aging Population.” We invite you to come and hear how provincial and federal governments could work strategically to make medicines safer and more affordable for all. Dr. Steven G. Morgan is a Professor of Health Policy at UBC in the School of Population and Public Health.
He is an expert in pharmaceutical policy. He has published hundreds of research papers and has served as an expert advisor to governments in Canada and overseas. His current focus is on designing policies to achieve “Triple A” outcomes: Access to medicines, Appropriate prescribing and Affordable prices. Join the discussion following Dr. Morgan’s presentation. Joyce Murray and Isobel Mackenzie will make brief statements addressing the issues.
Safely tucked into our subconscious
According to the Alzheimer’s Society of Canada calendar, April 4th was National Caregivers Day…and like most caregivers, I was too busy to pay it much attention! So today, I thought it fitting I post something to recognize caregivers after all the focus we had at SLC on preparing a report for government on the topic. I was reminded of a satirical article that appeared in an online publication called the Onion*. (yikes, I hope my kids can do better than tucking me away in their subconscious!) Continue reading
Schizophrenic Cactus celebrates Easter
With Easter celebrations soon upon us, I thought you might enjoy this poem sent to me by my friend Margaret…( you will remember Margaret from my first blog post – she endured considerable strife arising from a Representation Agreement signed by her husbands’ adult children that revoked her rights to care for her husband. Sadly, Bob passed away in a nursing home from Alzheimers). Continue reading
LPC New Policy Development Process
In 2016 the Liberal Party of Canada committed to finalizing a new Constitution and Bylaws. Of key importance is the bylaw pertaining to how EDAs and the Commissions will engage with our communities to gather information on issues of relevance that could influence policy and party platform. In Vancouver, Sunday, March 26, 5:30 – 7:30pm you can become informed on the new process and have input on how to make it work at the local level. This initiative is organized by four Vancouver EDAs and representatives from the BC Senior Liberals Commission. Doug, MacDonald, National and Provincial Policy Chair for the Senior Liberals Commission will speak to the proposed BCSLC plan to support the national guidelines.